Tetra Pharm is aimed to improve treatment of neuropathic pain and mental health disorders.
Tetra Pharm has raised $9.8M in total funding. The most recent round was Series A. The last funding was announced in January 2023.
Tetra Pharm is headquartered in Copenhagen, Denmark.
Tetra Pharm is aimed to improve treatment of neuropathic pain and mental health disorders.
Tetra Pharm is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tetra Pharm — Funding & Investors." VCBacked, January 26, 2023, https://www.vcbacked.co/company/tetra-pharm. Accessed August 14, 2026.
VCBacked. (2023). Tetra Pharm — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/tetra-pharm
{{cite web |title=Tetra Pharm — Funding & Investors |url=https://www.vcbacked.co/company/tetra-pharm |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated